Concepedia

Guolong Luo

GL

Statistics

Publications

4

Citations

95

H-Index

4

Active since

2019

Affiliations

Guangzhou Institutes of Biomedicine and Health(Current)

Guangzhou Medical University

University of Chinese Academy of Sciences

Chinese Academy of Sciences

State Key Laboratory of Respiratory Disease

Guolong Luo is an author at Guangzhou Institutes of Biomedicine and Health specializing in medicinal chemistry, drug development, and drug discovery.

Top concepts

Publications per year

2019–2024

4

Publications

4

Design, Synthesis, and Biological Evaluation of 1-(Indolizin-3-yl)ethan-1-ones as CBP Bromodomain Inhibitors for the Treatment of Prostate Cancer

Qiuping Xiang, Chao Wang, Tianbang Wu et al. · Journal of Medicinal Chemistry · 2021 · 47 citations · Full text

Discovery and optimization of novel N-benzyl-3,6-dimethylbenzo[d]isoxazol-5-amine derivatives as potent and selective TRIM24 bromodomain inhibitors with potential anti-cancer activities

Qingqing Hu, Chao Wang, Qiuping Xiang et al. · Bioorganic Chemistry · 2019 · 18 citations

, , +7

Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors

Qiuping Xiang, Guolong Luo, Cheng Zhang et al. · European Journal of Medicinal Chemistry · 2022 · 15 citations · Full text

, , +7

Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong <i>In Vivo</i> Antitumor Activity

Jiankang Hu, Hongrui Xu, Tianbang Wu et al. · Journal of Medicinal Chemistry · 2024 · 15 citations · Full text

1–4 of 4